Trademark: 88939380
Status Date
Monday, January 2, 2023
Filing Date
Friday, May 29, 2020
Published for Opposition
Tuesday, October 6, 2020
Abandoned Date
Monday, January 2, 2023
5 pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contraceptive preparations and substances; hormone replacement therapy preparations; hormonal agents for treating disorders and conditions related to women's health, namely, symptoms and conditions associated with menopause, pre-menstruation syndrome and other symptoms and conditions associated with menstruation
Jan 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 2, 2023
Abandonment - No Use Statement Filed
May 21, 2022
Notice Of Approval Of Extension Request E-Mailed
May 19, 2022
Sou Extension 3 Granted
May 19, 2022
Sou Extension 3 Filed
May 19, 2022
Teas Extension Received
Dec 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2021
Sou Extension 2 Granted
Nov 30, 2021
Sou Extension 2 Filed
Nov 30, 2021
Teas Extension Received
Apr 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 13, 2021
Sou Extension 1 Granted
Apr 13, 2021
Sou Extension 1 Filed
Apr 13, 2021
Teas Extension Received
Dec 1, 2020
Noa E-Mailed - Sou Required From Applicant
Oct 6, 2020
Official Gazette Publication Confirmation E-Mailed
Oct 6, 2020
Published For Opposition
Sep 16, 2020
Notification Of Notice Of Publication E-Mailed
Aug 28, 2020
Approved For Pub - Principal Register
Aug 28, 2020
Examiner's Amendment Entered
Aug 28, 2020
Notification Of Examiners Amendment E-Mailed
Aug 28, 2020
Examiners Amendment E-Mailed
Aug 28, 2020
Examiners Amendment -Written
Aug 20, 2020
Assigned To Examiner
Jun 19, 2020
New Application Office Supplied Data Entered In Tram
Jun 2, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
